Pfizer running COVID-19 human vaccine trials
The vaccine carries a genetic code known as messenger RNA. It attempts to reprogram the virus rather than manipulate the live virus.
•
May 6, 2020, 10:17 AM
•
Updated 1,690 days ago
Share:
Pfizer and New York University are working on a vaccine for COVID-19.
The vaccine carries a genetic code known as messenger RNA. It attempts to reprogram the virus rather than manipulate the live virus.
Researchers hope the body's immune system will then kick in, creating the antibodies needed to fight off COVID-19.
The group started testing the vaccine on people this week.
This is phase one of the trial, but if proven safe, Pfizer said it could make 20 million doses by the end of the year.
More from News 12
1:45
Cold, dry conditions to round out the weekend on Long Island
2:00
Long Island faces snowfall ahead of holiday season
Stolen base king Rickey Henderson dies at 65
0:47
Walt Whitman High School hosts second annual 'Holiday Blessings Tour'
0:18
Police: Driver fled scene after crashing into East Patchogue deli
0:27
